TY - JOUR
T1 - Incidental Detection of Urothelial Carcinoma on 18F-Fluciclovine PET/CT
AU - Surasi, Devaki Shilpa Sudha
AU - Lu, Yang
AU - Corn, Paul
AU - Pettaway, Curtis
AU - Bathala, Tharakeswara
N1 - Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2021
Y1 - 2021
N2 - 18F-Fluciclovine PET/CT has become a common diagnostic imaging study used in the evaluation of biochemical recurrence in prostate cancer since its approval in 2016. We present a case report of an 82-year-old man with history of both prostate and bladder cancer who presented for a fluciclovine study due to rising PSA levels. There was incidental detection of focal penile activity, and a subsequent urethral biopsy performed showed urothelial carcinoma, which was also seen on a subsequent MRI study.
AB - 18F-Fluciclovine PET/CT has become a common diagnostic imaging study used in the evaluation of biochemical recurrence in prostate cancer since its approval in 2016. We present a case report of an 82-year-old man with history of both prostate and bladder cancer who presented for a fluciclovine study due to rising PSA levels. There was incidental detection of focal penile activity, and a subsequent urethral biopsy performed showed urothelial carcinoma, which was also seen on a subsequent MRI study.
KW - F-fluciclovine PET/CT
KW - prostate cancer
KW - urothelial carcinoma
UR - http://www.scopus.com/inward/record.url?scp=85099324429&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099324429&partnerID=8YFLogxK
U2 - 10.1097/RLU.0000000000003342
DO - 10.1097/RLU.0000000000003342
M3 - Article
C2 - 33156041
AN - SCOPUS:85099324429
SN - 0363-9762
VL - 46
SP - e114-e115
JO - Clinical nuclear medicine
JF - Clinical nuclear medicine
IS - 2
ER -